MLL Munich Leukemia Laboratory
What we offer
Diagnostics
We are interdisciplinary experts. Our goal is to provide the best leukemia diagnostics for our patients by offering a comprehensive set of methods, state-of-the-art technology and continuous development.
Big Data
We empower physicians, biologists, scientists, and researchers with web-based tools that assist in variant interpretation of sequencing data in hematologic neoplasms.
Pharma
We have a wealth of experience supporting clinical research from clinical trial design to post-launch diagnostics.
Research
Through a large number of in-house scientific projects as well as national and international collaborations, we contribute to the improvement of leukemia and lymphoma diagnostics and risk stratification of patients.
Methods
Focused methods for leukemia diagnostics form the basis for a specific therapy.
Corporate film 2020
About us
News
Genome Network Hematology
We have founded the Genome Network Hematology - together with the Comprehensive Cancer Center Klinikum rechts der Isar TUM and the Comprehensive Cancer Center Mainfranken/Universitätsklinikum Würzburg. The new Genome Network Hematology pursues the goal of establishing a forward-looking patient care system that combines research and practice. By combining research results and patient data, we create a feedback loop that generates new insights and continuously improves patient care. In this way, we aim to advance personalized medicine in hematology and anchor it in patient care.
You may also be interested in
Your contact person
»Patient wellbeing and digitalization are not a contradiction, but the future.«
Prof. Dr. med. Dr. phil. Torsten Haferlach
Executive management
Internist, Hematologist and Oncologist
torsten.haferlach@mll.com